11-year-old Peter is a keen gamer and loves all things Lego and playing Minecraft. He enjoys spending time cycling, swimming and crafting, especially drawing and cross-stitching and his favourite animal is a rabbit!
On New Year's Eve 2018, after complaining of backache and tingles in one leg it was confirmed that Peter had a growth in his thorax that was pressing on his spinal cord, causing a spinal cord injury. After emergency surgery, his spinal cord injury did not make the immediate recovery that was hoped for, leaving him with no movement or sensation in his lower body. Days after the surgery his parents were given the devastating news that the growth in his thorax was neuroblastoma.
After enduring intense frontline treatment, Peter was no evidence of disease in February 2020. Just 6 months later, in August 2020, after noticing a lump on his skull, parents Mandy and Martin were told that Peter had sadly relapsed with the disease spreading throughout his body.
The family have decided to start fundraising for further treatment either to get Peter back into remission or to try and keep the cancer away if his treatment goes to plan. This could cost hundreds of thousands of pounds.
Peter's Winter Wonderland
 |
Solving Kids' Cancer UK
Published: 11 Oct 2021
Beneficiary
 |
Solving Kids' Cancer UK Charity no. 1135601 Email: fundraising@solvingkidscancer.org.uk Tel: 020 7284 0800 |
Solving Kids' Cancer UK
Charity no. 1135601
Email: fundraising@solvingkidscancer.org.uk
Tel: 020 7284 0800
Solving Kids’ Cancer is a huge-hearted, child-focussed, and family-led charity that supports children affected by the childhood cancer neuroblastoma, and their families.
Neuroblastoma is an often-aggressive childhood cancer, which affects around 100 children every year in the UK. Solving Kids’ Cancer fights for a future where no child dies of the childhood cancer neuroblastoma or suffers due to its treatment. We do this by: providing hope, information and support to families throughout their journeys; facilitating access to treatment in partnership with clinicians and researchers; advancing science through investment and clinical research and advocating for more effective and less toxic treatments.
